Randomised Trials and Informed Consent
Lancet. 1988 Oct 29; 2(8618): 1033-1034.
A British barrister analyzes the strengths and weaknesses of the recommendations of the Medical Research Council's Cancer Therapy Committee on the ethical aspects of cancer treatment trials. Although the medical community criticizes the requirements of informed consent and randomized controlled trials because of the practical difficulties they create, both are ideals which must be pursued. If patients do not accept that all of the options in a randomized trial are equal and refuse to participate in the trial, initiatives must be taken to ensure that the choices offered are truly equal and that the public and the medical profession are better able to communicate with each other. (KIE abstract)
Showing items related by title, author, creator and subject.